In summary, the present paper showed the important regulatory effect of S100A9 in pancreatic duct injury in AP, and inhibition of the S100A9-VNN1 interaction may be a key therapeutic target for this disease. The gene discussed is VNN1; the disease is alkaline phosphatase measurement.